ChengDa Pharmaceuticals Co. Ltd. Capital Reinvestment Ratio
ChengDa Pharmaceuticals Co. Ltd. capital reinvestment ratio. ChengDa Pharmaceuticals Co. Ltd. (301201) has a Capital Reinvestment Ratio of 2.03x as of December 2025, meaning it reinvests 2% of its operating cash flow (CN¥34.02 Million) in capital expenditures (CN¥69.02 Million). See 301201 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of ChengDa Pharmaceuticals Co. Ltd. (2019–2025)
Capital reinvestment ratio of ChengDa Pharmaceuticals Co. Ltd. from 2019 to 2025. This chart tracks ChengDa Pharmaceuticals Co. Ltd.'s Capital Reinvestment Ratio across 7 annual periods. See ChengDa Pharmaceuticals Co. Ltd. leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
ChengDa Pharmaceuticals Co. Ltd. Capital Reinvestment Ratio by Year (2019–2025)
ChengDa Pharmaceuticals Co. Ltd. capital reinvestment ratio by year from 2019 to 2025. For the full cash flow conversion analysis, see cash flow conversion of ChengDa Pharmaceuticals Co. Ltd..
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 2.03x | CN¥34.02 Million | CN¥69.02 Million | ▼ -79.7% |
| 2024 | 10.00x | CN¥28.65 Million | CN¥286.36 Million | ▲ +754.6% |
| 2023 | 1.17x | CN¥192.07 Million | CN¥224.67 Million | ▼ -72.9% |
| 2022 | 4.32x | CN¥47.67 Million | CN¥205.69 Million | ▲ +158.7% |
| 2021 | 1.67x | CN¥83.14 Million | CN¥138.70 Million | ▲ +237.2% |
| 2020 | 0.49x | CN¥128.97 Million | CN¥63.81 Million | ▼ -34.6% |
| 2019 | 0.76x | CN¥67.52 Million | CN¥51.06 Million | — |